Early acyclovir for herpes in ventilated patients
Part of Infections, Lungs & breathing clinical trials.
This study tests whether giving acyclovir early—before symptoms appear—can help patients on a breathing machine who have a herpes virus in their throat. It aims to see if treatment can prevent complications and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have been on a breathing machine for at least 4 days and need it for at least 2 more days.
- You must have a positive throat swab for herpes simplex virus (HSV).
- You must have little to no organ failure (no more than one organ failing).
- You cannot have taken any antiviral medication for herpes in the last 30 days.
- You cannot have a weakened immune system (e.g., from HIV, an organ transplant, or high-dose steroids).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether acyclovir, an antiviral drug, can help patients with pneumonia who are on breathing support and have herpes simplex virus in their lung fluid. The goal is to see if it improves recovery.
This study compares acyclovir (an antiviral medicine) to placebo (inactive treatment) in adults with HSV-2 meningitis. It aims to see whether acyclovir helps people recover faster or better after this infection of the lining around the brain.
This study checks how acyclovir behaves in the body when it’s given by mouth or through an IV to children receiving cancer care. It may help doctors better choose doses and monitor the medicine in kids who need prevention or treatment of certain viral infections.
This study looks at whether a common virus (herpes simplex virus type 1) becomes active in patients with severe pneumonia in the ICU. Understanding this may help improve treatment and care.
This study looks at whether a common virus called cytomegalovirus (CMV) becomes active again in ICU patients who need a breathing machine for a week or more. It may help doctors understand who is at risk and how to better care for them.
This trial tests whether a medicine called acyclovir can prevent herpes simplex outbreaks in people who also have an autoimmune rheumatic disease. It may help reduce the number of painful cold sores or genital herpes episodes you experience.
Hear when a new Invasive Mechanical Ventilation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.